Clinical Trial Update: A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases [Phase 1]

View source ↗

Summary

Phase 1 pharmacodynamic study of AV-299 (formerly SCH 900105) in subjects with advanced solid tumors and liver metastases has been completed. The study evaluate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Solid Tumor

Drugs mentioned

• AV-299

Snippet

Sponsor: AVEO Pharmaceuticals, Inc. | Conditions: Malignant Solid Tumour, Liver Metastases | Phase 1 | Status: COMPLETED